|
Media Releases |
Financial Reports |
Presen-tations |
|
10/17/2006
|
|
|
|
| Third Quarter Business Update |
Lonza will today hold a conference call for analysts, investors and business media to provide its third quarter business update and outlook for 2006.
Lonza is confident it is on track to meet market expectations for full year results. It also confirms that the planned Initial Public Offering of Polynt SpA is underway.
Slides will be available on the website:
http://www.lonza.com/group/en/company/news/speeches.html from 8.00 a.m. CET.
To access the webcast being held at 9:30 a.m. CET, Swiss and European callers (except the U.K.) may call +41 91 610 5600, while U.K. callers may dial +44 207 107 0611. North American callers may dial +1 866 291 4166.
The call is scheduled for one hour and will be held in English.
From 3:00 p.m. CET on, it will be possible to access via our website
http://www.lonza.com/group/en/company/investor.html the recorded Conference Call and accompanying presentation.
About Lonza
Lonza, a chemical and biotechnology company driven by the life sciences, generated sales of CHF 2.52 billion in 2005. Headquartered in Switzerland, Lonza operates 23 production and R&D sites around the world. Its 6400 employees are passionately committed to delivering sustainable value to their customers. Lonza is one of the leading custom manufacturers of chemical intermediates, active ingredients and biopharmaceuticals for the pharmaceutical and agrochemical industries. On the basis of organic and performance chemicals and biotechnology platforms, Lonza creates value-added solutions for the nutrition, hygiene & personal care, wood & water treatment and industrial specialty markets. Lonza also offers polymer intermediates, resins and compounds. Lonza is listed on the SWX Swiss Exchange. Further information can be found on our website www.lonza.com.
For further information:
Margot Connor
Tel +41 61 316 8566
Fax +41 61 316 9566
Mobile +41 79 401 2832
margot.connor@lonza.com
|
|
|
